Get started
Author

Ibtissem Kadi

Observed names: IBTISSEM KADI, Kadi, Ibtissem
ORCID: 0000-0003-0408-0135
Observed ORCID: 0000-0003-0408-0135
OpenAlex ID: A5002253958
Synthesis, in vitro, and in silico studies of novel poly‐heterocyclic compounds bearing pyridine and furan moieties as potential anticancer agents
2022 · Ibtissem Kadi, Güldeniz Şekerci, et al. · Journal of Molecular Structure · 18
Exploring the anticancer potential of new 3‐cyanopyridine derivatives bearing N‐acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties
2024 · Ibtissem Kadi, Güldeniz Şekerci, et al. · Journal of Biochemical and Molecular Toxicology · 9
Synthesis, Cytotoxicity, Antioxidant Activity, DFT Calculations, and Docking Studies of New Pyridine-Malonate Derivatives as Potential Anticancer Agents
2023 · Ibtissem Kadi, Şekerci Güldeniz, et al. · Polycyclic aromatic compounds · 9
Novel 2‐Alkoxy‐3‐Cyanopyridine Derivatives as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, and In Silico Investigations
2025 · Ibtissem Kadi, Gökçe Seyhan, et al. · Chemistry & Biodiversity · 4
Discovery and characterization of selective lipase-inhibiting polyheterocyclic derivatives: a combined in silico and in vitro study
2025 · MADJDA BENGUECHOUA, MEBARKA IMANE BENGUECHOUA, et al. · TURKISH JOURNAL OF BIOLOGY · 1
PDF
Works count: 6
Citation count: 41
H-index: 4
I10-index: 1
Year
Topic
Type